Research and Markets: Women Infertility Pipeline Review, H1 2015

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/vcq6d6/women_infertility) has announced the addition of the "Women Infertility - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Women Infertility, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Women Infertility and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

  • AbbVie Inc.
  • Actavis plc
  • Addex Therapeutics Ltd
  • AlphaMab Co., Ltd
  • APAvadis Biotechnologies Srl
  • ASKA Pharmaceutical Co., Ltd.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Crinetics Pharmaceuticals, Inc.
  • Dong-A Socio Group
  • Dongkook Pharmaceutical Co., Ltd.
  • EffRx Pharmaceuticals S.A.
  • ElexoPharm GmbH
  • EndoCeutics, Inc.
  • Euroscreen S.A.
  • Evotec AG
  • Ferring International Center S.A.
  • Finox AG
  • Forendo Pharma Oy
  • GlaxoSmithKline plc
  • Glycotope GmbH
  • Isifer AB
  • Kissei Pharmaceutical Co., Ltd.
  • Lipicard Technologies Limited
  • Merck & Co., Inc.
  • Merck KGaA
  • Neurocrine Biosciences, Inc.
  • Nora Therapeutics, Inc.
  • ObsEva SA
  • Orphagen Pharmaceuticals, Inc.
  • Pantec Biosolutions AG
  • PharmaEssentia Corporation
  • Philogen S.p.A.

For more information visit http://www.researchandmarkets.com/research/vcq6d6/women_infertility

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Women's Health

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Women's Health